Neurobo Pharmaceuticals Correlations

NRBO Stock  USD 2.35  0.05  2.08%   
The current 90-days correlation between Neurobo Pharmaceuticals and ZyVersa Therapeutics is 0.02 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurobo Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurobo Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Neurobo Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Neurobo Pharmaceuticals and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurobo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
To learn how to invest in Neurobo Stock, please use our How to Invest in Neurobo Pharmaceuticals guide.

Moving together with Neurobo Stock

  0.68VRAX Virax Biolabs GroupPairCorr
  0.71VRPX Virpax PharmaceuticalsPairCorr
  0.63DYN Dyne TherapeuticsPairCorr
  0.79XFOR X4 PharmaceuticalsPairCorr
  0.7JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.82MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.67INZY Inozyme PharmaPairCorr
  0.84KURA Kura OncologyPairCorr
  0.64PALI Palisade BioPairCorr
  0.74STOK Stoke TherapeuticsPairCorr
  0.83BDRX Biodexa Pharmaceticals Upward RallyPairCorr
  0.65TERN Terns PharmaceuticalsPairCorr
  0.7PPERY Bank Mandiri PerseroPairCorr
  0.72PPERF Bank Mandiri PerseroPairCorr
  0.68BKRKF PT Bank RakyatPairCorr

Moving against Neurobo Stock

  0.83EWTX Edgewise TherapeuticsPairCorr
  0.76PRAX Praxis Precision MedPairCorr
  0.74AMLX Amylyx PharmaceuticalsPairCorr
  0.69AKRO Akero TherapeuticsPairCorr
  0.68ALVO AlvotechPairCorr
  0.64VRDN Viridian TherapeuticsPairCorr
  0.49CRNX Crinetics PharmaceuticalsPairCorr
  0.42NTRB NutribandPairCorr
  0.37BMEA Biomea FusionPairCorr
  0.89SSNLF Samsung ElectronicsPairCorr
  0.87AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.83CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.81PTAIF PT Astra InternationalPairCorr
  0.81CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.81HD Home DepotPairCorr
  0.78WMT Walmart Aggressive PushPairCorr
  0.78XOM Exxon Mobil Corp Aggressive PushPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SONNZVSA
PHIOSONN
RNAZZURA
PHIOZVSA
QNRXZURA
PHIOZURA
  
High negative correlations   
RNAZSONN
RNAZZVSA
QNRXPHIO
ZURAZVSA
QNRXZVSA
QNRXRNAZ

Risk-Adjusted Indicators

There is a big difference between Neurobo Stock performing well and Neurobo Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neurobo Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Neurobo Pharmaceuticals Corporate Management